Jonathan R. Day, MD, PharmD, and Brian K. Link, MD, give their perspective on emerging treatments for follicular lymphoma.
Jonathan R. Day, MD, PharmD
Advertisement
Articles by Jonathan R. Day, MD, PharmD
Advertisement
Latest Updated Articles
Perspectives on Follicular Lymphoma Treatment From New and Experienced Clinicians: New, Old, & Old Is NewPublished: February 17th 2022 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Subcutaneous Daratumumab in High-Risk Smoldering Multiple Myeloma
2
Daratumumab Approval May Be “Game Changer” in High-Risk Smoldering Myeloma
3
How ADCs are Replacing Chemotherapy as Breast Cancer Treatment
4
Palazestrant Combo Shows Preliminary Activity in ER+/HER2– Breast Cancer
5
